A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
A dose escalation, safety study of local (intra-arterially) delivered gemcitabine to the
pancreas using the RenovoCath R120 catheter to determine the maximum tolerated dose.